Genomed is a biotechnology startup founded in 1991 that specializes in developing and adapting cutting-edge technology for molecular diagnostic laboratories. With over 20 years of experience in Clinical Genetics and DNA-based Forensics testing, Genomed has established itself as a frontrunner in these technologies. The company operates through two divisions, focusing on the development, manufacture, and distribution of molecular diagnostic tests, as well as the establishment of complete turn-key molecular laboratories. Its expertise spans across industries such as Biotechnology, Manufacturing, as well as Privacy and Security. As of now, there is no publicly disclosed information on Genomed's headquarters, last investment, or the investors involved.
There is no investment information
No recent news or press coverage available for Genomed.
We care about your data, and we'd love to use cookies make your experience better.
